Skip to main content
Erschienen in:

01.06.2019 | Case report

Infliximab

Intestinal tuberculosis: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Shen Y, et al. The T-SPOT.TB assay used for screening and monitoring of latent tuberculosis infection in patients with Behcet's disease pre- and post-anti-TNF treatment: A retrospective study. Journal of the Chinese Medical Association 82: 375-380, No. 5, May 2019. Available from: URL: http://doi.org/10.1097/JCMA.0000000000000071 - China Shen Y, et al. The T-SPOT.TB assay used for screening and monitoring of latent tuberculosis infection in patients with Behcet's disease pre- and post-anti-TNF treatment: A retrospective study. Journal of the Chinese Medical Association 82: 375-380, No. 5, May 2019. Available from: URL: http://​doi.​org/​10.​1097/​JCMA.​0000000000000071​ - China
Metadaten
Titel
Infliximab
Intestinal tuberculosis: case report
Publikationsdatum
01.06.2019
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2019
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-019-63746-2